Concepedia

Tom S. Chen

TS

9

Publications

281

Citations

9

H-Index

1989

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Purdue University West Lafayette

Tom S. Chen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biochemistry, biosynthesis, and drug discovery.

Top concepts

Publications per year

1989–2007

9

Publications

9

Use of Near-Infrared Spectroscopy to Evaluate an Active in a Film Coated Tablet

B. R. Buchanan, Mark A. Baxter, Tom S. Chen et al. · Pharmaceutical Research · 1996 · 68 citations

D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent<i>in vitro</i>and<i>in vivo</i>antitumoral activity which involves DNA damage and ataxia telangiectasia–mutated nuclear protein kinase activation

Shin‐Hun Juang, Chia-Chi Lung, Pi-Chen Hsu et al. · Molecular Cancer Therapeutics · 2007 · 65 citations

Further studies on the biosynthesis of the avermectins

Tom S. Chen, Byron H. Arison, Vincent P. Gullo et al. · Journal of Industrial Microbiology & Biotechnology · 1989 · 28 citations · Full text

Directed biosynthesis of avermectins

Tom S. Chen, Edward Inamine, Otto D. Hensens et al. · Archives of Biochemistry and Biophysics · 1989 · 24 citations

, , +2

Microbial transformation of immunosuppressive compounds. I. Desmethylation of FK 506 and immunomycin (FR 900520) by Actinoplanes sp. ATCC 53771.

Tom S. Chen, Byron H. Arison, Linda S. Wicker et al. · The Journal of Antibiotics · 1992 · 24 citations · Full text

Rows per page

1–5 of 9